Silphium Asset Management’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

Silphium Asset Management’s Portfolio AVEO Stock Details AVEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-100,000	Closed	-$1.5M	–	54
2022 Q4	$1.5M	Buy	+100,000	New	+$1.38M	1.49%	23
2018 Q4	–	Sell	-6,500	Closed	-$215K	–	115
2018 Q3	$215K	Buy	+6,500	New	+$167K	0.06%	110

Silphium Asset Management's AVEO Position: Q1 2023 in Review

Silphium Asset Management sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q1 2023, closing a stake of 100,000 shares — an estimated $1.5M sold.

Silphium Asset Management first reported a position in AVEO in Q3 2018 and held it in 2 quarters. The position peaked at $1.5M in Q4 2022. 0 funds tracked by Wall St. Rank hold AVEO as of Q1 2023.

Silphium Asset Management reported no remaining AVEO Pharmaceuticals, Inc. position as of Q1 2023 after selling out during the quarter.
Silphium Asset Management sold 100,000 AVEO Pharmaceuticals, Inc. shares in Q1 2023, an estimated $1.5M.
Silphium Asset Management first reported a position in AVEO Pharmaceuticals, Inc. in Q3 2018 and held it in 2 quarters.
Silphium Asset Management's AVEO Pharmaceuticals, Inc. position peaked at $1.5M in Q4 2022.
0 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q1 2023.

Based on Silphium Asset Management's 13F filing for Q1 2023, filed 30 Jan 2025.